Jianhao Xu

529 total citations
25 papers, 382 citations indexed

About

Jianhao Xu is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Jianhao Xu has authored 25 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Jianhao Xu's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jianhao Xu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jianhao Xu collaborates with scholars based in China and United States. Jianhao Xu's co-authors include Yusong Zhang, Jialong Tao, Liwei Ni, Na Yu, Yuming Long, Anqi Jin, Aiming Shi, Cunjin Su, Jie Pan and Ze Xiang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and Atmospheric Environment.

In The Last Decade

Jianhao Xu

21 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianhao Xu China 11 153 116 76 43 39 25 382
Helene Hildegard Heidegger Germany 14 220 1.4× 113 1.0× 150 2.0× 31 0.7× 44 1.1× 45 510
Hui-Wen Chang Taiwan 14 290 1.9× 85 0.7× 108 1.4× 17 0.4× 45 1.2× 24 518
Da Wo China 12 203 1.3× 58 0.5× 47 0.6× 17 0.4× 17 0.4× 32 393
Xiaobo Wang China 9 117 0.8× 41 0.4× 52 0.7× 15 0.3× 33 0.8× 30 336
Manal L. Louka Egypt 12 173 1.1× 119 1.0× 45 0.6× 18 0.4× 11 0.3× 26 359
Dagmar Richter Germany 9 156 1.0× 106 0.9× 155 2.0× 23 0.5× 16 0.4× 19 448
Eslam E. Abd El-Fattah Egypt 14 256 1.7× 72 0.6× 91 1.2× 7 0.2× 26 0.7× 18 496
Zhao Liu China 12 162 1.1× 95 0.8× 167 2.2× 8 0.2× 19 0.5× 43 446
İlhan Yaylım Türkiye 13 173 1.1× 77 0.7× 82 1.1× 8 0.2× 10 0.3× 59 438

Countries citing papers authored by Jianhao Xu

Since Specialization
Citations

This map shows the geographic impact of Jianhao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhao Xu more than expected).

Fields of papers citing papers by Jianhao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhao Xu. The network helps show where Jianhao Xu may publish in the future.

Co-authorship network of co-authors of Jianhao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhao Xu. A scholar is included among the top collaborators of Jianhao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhao Xu. Jianhao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Yihan, Wanqing Wei, Jianhao Xu, et al.. (2025). Semirational Design of 4-Hydroxyphenylpyruvate Dioxygenase for Efficient and Regioselective Production of 3-Hydroxy-3-methylbutyrate. Journal of Agricultural and Food Chemistry. 73(17). 10482–10493.
3.
Xu, Jianhao, et al.. (2024). Intravascular Leiomyoma Considered Preoperatively as Uterine Sarcoma: A Rare Case. Women s Health Reports. 5(1). 334–339.
4.
Zhou, Qi, et al.. (2024). CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical research. Frontiers in Oncology. 14. 1445526–1445526. 2 indexed citations
6.
Xu, Jianhao, et al.. (2022). CNS and CNS diseases in relation to their immune system. Frontiers in Immunology. 13. 1063928–1063928. 22 indexed citations
7.
Cao, Fang, et al.. (2021). Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 19(1). 89–89. 13 indexed citations
8.
Ni, Liwei, Jianhao Xu, Jialong Tao, et al.. (2021). MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo. European Journal of Pharmacology. 899. 174054–174054. 21 indexed citations
9.
Xu, Jianhao, Fang Cao, Fang Chen, et al.. (2021). Diagnostic Role of Long Non-Coding RNAs in Breast Cancer: a Systematic Review and Meta-Analysis. Clinical Laboratory. 67(03/2021). 4 indexed citations
10.
Yu, Na, Jianhao Xu, Liwei Ni, et al.. (2019). Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status. Translational Cancer Research. 8(5). 1690–1698. 2 indexed citations
12.
Ni, Liwei, Yuming Long, Jialong Tao, et al.. (2019). Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. 19(1). 323–323. 41 indexed citations
13.
Yu, Na, Jianhao Xu, Liwei Ni, et al.. (2019). Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status. Translational Cancer Research. 8(5). 1690–1698. 6 indexed citations
14.
Xu, Jianhao, Yuming Long, Liwei Ni, et al.. (2019). Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 19(1). 589–589. 59 indexed citations
15.
Ni, Liwei, Jialong Tao, Jianhao Xu, et al.. (2019). Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 301(1). 251–261. 37 indexed citations
16.
Su, Cunjin, Jianhao Xu, Aiming Shi, et al.. (2019). X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activation. Molecular Pain. 15. 2225652977–2225652977. 9 indexed citations
17.
Xu, Jianhao, Cunjin Su, Jialong Tao, et al.. (2018). Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation. Biochemical and Biophysical Research Communications. 504(1). 123–128. 40 indexed citations
18.
Xu, Jianhao, et al.. (2018). The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis. Neoplasma. 66(1). 73–82. 7 indexed citations
19.
Jin, Anqi, et al.. (2018). The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer. Medicine. 97(29). e11548–e11548. 36 indexed citations
20.
Sun, Shutao, et al.. (2015). 2398 Prognostic significance of tumour-infiltrating immune cells and PD-L1 expression in oesophageal squamous cell carcinoma in Chinese patients. European Journal of Cancer. 51. S469–S470. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026